These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 16906369)

  • 1. The clinical application of etanercept in Chinese patients with rheumatic diseases.
    Chou CT
    Mod Rheumatol; 2006; 16(4):206-13. PubMed ID: 16906369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide series.
    Toussirot É; Houvenagel É; Goëb V; Fouache D; Martin A; Le Dantec P; Dernis E; Wendling D; Ansemant T; Berthelot JM; Bader-Meunier B; Kantelip B;
    Joint Bone Spine; 2012 Oct; 79(5):457-63. PubMed ID: 22088934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.
    Favalli EG; Pontikaki I; Becciolini A; Biggioggero M; Ughi N; Romano M; Crotti C; Gattinara M; Gerloni V; Marchesoni A; Meroni PL
    Clin Rheumatol; 2017 Aug; 36(8):1747-1755. PubMed ID: 28597133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis.
    Haberhauer G; Strehblow C; Fasching P
    Wien Med Wochenschr; 2010 May; 160(9-10):220-4. PubMed ID: 20632149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Better short-term clinical response to etanercept in Chinese than Caucasian patients with active ankylosing spondylitis.
    Chou CT; Tsai CY; Liang TH; Chang TM; Lai CH; Wei CC; Chen KH; Lin SC; Yu CL; Liou LB; Luo SF; Lee CS; Hsue YT; Huang CM; Chen JH; Lai NS; Cheng HH; Cheng TT; Lai HM; Tsai WC; Yen JH; Lu LY; Chang CP
    Mod Rheumatol; 2010 Dec; 20(6):580-7. PubMed ID: 20683633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The soluble tumor necrosis factor receptor etanercept: a new strategy for the treatment of autoimmune rheumatic disease.
    Cole P; Rabasseda X
    Drugs Today (Barc); 2004 Apr; 40(4):281-324. PubMed ID: 15190385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy.
    Rudwaleit M; Van den Bosch F; Kron M; Kary S; Kupper H
    Arthritis Res Ther; 2010; 12(3):R117. PubMed ID: 20553600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF-alpha therapy for ankylosing spondylitis.
    Son JH; Cha SW
    Clin Orthop Surg; 2010 Mar; 2(1):28-33. PubMed ID: 20190998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and economic impact of the use of etanercept 25 mg once weekly in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis patients.
    Borrás-Blasco J; Gracia-Pérez A; Rosique-Robles JD; Casterá ME; Abad FJ
    Expert Opin Biol Ther; 2014 Feb; 14(2):145-50. PubMed ID: 24359492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.
    Huscher D; Merkesdal S; Thiele K; Zeidler H; Schneider M; Zink A;
    Ann Rheum Dis; 2006 Sep; 65(9):1175-83. PubMed ID: 16540552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk: benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis.
    Fleischmann R; Iqbal I
    Drugs Aging; 2007; 24(3):239-54. PubMed ID: 17362051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biologicals in the treatment of rheumatic diseases].
    Scherer HU; Burmester GR
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2279-85. PubMed ID: 17036270
    [No Abstract]   [Full Text] [Related]  

  • 14. Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial.
    Ruwaard J; L' Ami MJ; Kneepkens EL; Krieckaert C; Nurmohamed MT; Hooijberg F; van Kuijk A; van Denderen JC; Burgemeister L; Rispens T; Boers M; Wolbink GJ
    Scand J Rheumatol; 2023 Mar; 52(2):129-136. PubMed ID: 35234569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.
    Burmester GR; Panaccione R; Gordon KB; McIlraith MJ; Lacerda AP
    Ann Rheum Dis; 2013 Apr; 72(4):517-24. PubMed ID: 22562972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Educational session as a tool to increase patient satisfaction of switching etanercept from the prefilled syringe to the autoinjection pen.
    Borrás-Blasco J; Gracia-Pérez A; Casterá MD; Rosique-Robles JD; Abad J
    Expert Opin Biol Ther; 2013 Aug; 13(8):1103-8. PubMed ID: 23675687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis Patients at 4 Months' Follow-up After Treatment with Infliximab and Etanercept.
    Aghdashi MA; Khadir M; Dinparasti-Saleh R
    Curr Rheumatol Rev; 2020; 16(1):61-66. PubMed ID: 31057111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term safety of etanercept in elderly subjects with rheumatic diseases.
    Fleischmann R; Baumgartner SW; Weisman MH; Liu T; White B; Peloso P
    Ann Rheum Dis; 2006 Mar; 65(3):379-84. PubMed ID: 16150792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study.
    Arends S; Brouwer E; van der Veer E; Groen H; Leijsma MK; Houtman PM; Th A Jansen TL; Kallenberg CG; Spoorenberg A
    Arthritis Res Ther; 2011 Jun; 13(3):R94. PubMed ID: 21689401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of active rheumatoid arthritis after etanercept injection: a single-center experience.
    Su KY; Lee HT; Chou CT; Tsai ST; Chen WS; Tsai CY
    J Chin Med Assoc; 2009 Nov; 72(11):581-7. PubMed ID: 19948435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.